| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537635 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2018 | 88 Pages |
Abstract
Although some medications seem to enhance cognition in patients suffering from cognitive disorders, others could promote cognitive impairments, and our work highlights a lack of literature on this subject. In conclusion, more comparative clinical trials are needed to better understand the cognitive impact of addictolytic medications.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Camille Noélie Pujol, Cecilia Paasche, Vincent Laprevote, Benoit Trojak, Pierre Vidailhet, Elisabeth Bacon, Laurence Lalanne,